NCT00985088 - Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older | Biotech Hunter

Enrollment

1,343

Participants

Timeline

Start Date

October 11, 2009

Primary Completion Date

November 9, 2009

Study Completion Date

December 16, 2010

Conditions

Influenza

Interventions

BIOLOGICAL

GSK2340274A

one or two intramuscular injections

BIOLOGICAL

GSK2340273A

one or two intramuscular injections

BIOLOGICAL

Saline placebo

One injection

Trial Locations (14)

14609

GSK Investigational Site, Rochester

32216

GSK Investigational Site, Jacksonville

33143

GSK Investigational Site, Miami

35802

GSK Investigational Site, Huntsville

44122

GSK Investigational Site, Cleveland

59801

GSK Investigational Site, Missoula

66219

GSK Investigational Site, Lenexa

83642

GSK Investigational Site, Meridian

89104

GSK Investigational Site, Las Vegas

08817

GSK Investigational Site, Edison

V3R 8P8

GSK Investigational Site, Surrey

B2N 1L2

GSK Investigational Site, Truro

M9W 4L6

GSK Investigational Site, Toronto

H9R 4S3

GSK Investigational Site, Pointe-Claire